COVID-19 and persistent inflammation, immunosuppression and catabolism syndrome

被引:0
作者
Tatlisuluoglu, Derya [1 ]
Turan, Guldem [1 ]
机构
[1] Basaksehir Cam & Sakura Educ & Res City Hosp, Dept Intens Care Unit, Istanbul, Turkiye
来源
CUKUROVA MEDICAL JOURNAL | 2023年 / 48卷 / 02期
关键词
Persistent inflammation; immunosuppression; catabolism syndrome; PICS; COVID-19; CHRONIC CRITICAL ILLNESS; PROPRANOLOL; OXANDROLONE; DYSFUNCTION;
D O I
10.17826/cumj.1229091
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose: Multiple organ failure (MOF) is a disease group that necessitates intensive care monitoring and carries a significant mortality rate. If these individuals are not dead as a result of early MOF, they will either quickly restore immunological balance or their immunological dysfunction may persist, resulting in chronic critical illness (CCI). Some of these patients have CCI, which is characterized by chronic inflammation, immunosuppression, and the syndrome of catabolism (PICS). With this study, we aimed to evaluate PICS cases in our intensive care unit, their effects on mortality, and their biomarkers. Materials and Methods: This is a retrospective, observational study involving 190 patients diagnosed with acute respiratory distress syndrome (ARDS) due to SARS- CoV-2 and followed up in the ICU. Patients' laboratory data and body mass index (BMI) were compared between the first and twenty-first days of ICU admission. In addition, the patients were evaluated according to PICS utilizing the number of days they spent in the ICU, CRP, albumin, prealbumin, lymphocytes, and BMI data. Results: The laboratory values of the patients on the 21st day were as follows, and the results obtained were statistically significant when compared with the values on the 1st day. Albumin 2.56 & PLUSMN;0.57 g/L, prealbumin 9 & PLUSMN;15 g/L, d-dimer 4.41 & PLUSMN;4.70 (interquartile range (IQR): 2.53- 4.76) & mu;gFEU/mL, fibrinogen 497 & PLUSMN;189,35 mg/dl, hemoglobin 10.15 & PLUSMN;1.82 g/dL, leukocytes 13.94 & PLUSMN;8.12 (IQR: 12.34-7.69) 109/L, immature granulocyte 1.16 & PLUSMN;2.13 (IQR: 0.46-1)109/L and BMI of 26.92 & PLUSMN;3.27 (IQR: 26.7- 4.8). Again in these patients, lymphocyte values were 0.92 & PLUSMN;0.80 (IQR: 0.71-0.74)109/L, CRP was 101.42 & PLUSMN;99,96 mg/L, and platelet values were 214.24 & PLUSMN;128.08 109/L. Conclusion: PICS is a significant condition affecting mortality and morbidity in critical care patients. In this group of patients, immature granulocytes may also serve as a useful biomarker. Due to the lack of studies regarding PICS, we are in the premature phase of understanding the pathogenesis and management of PICS and therefore need more comprehensive research regarding the topic.
引用
收藏
页码:441 / 447
页数:7
相关论文
共 22 条
  • [1] Inflammation and sarcopenia: A systematic review and meta-analysis
    Bano, Giulia
    Trevisan, Caterina
    Carraro, Sara
    Solmi, Marco
    Luchini, Claudio
    Stubbs, Brendon
    Manzato, Enzo
    Sergi, Giuseppe
    Veronese, Nicola
    [J]. MATURITAS, 2017, 96 : 10 - 15
  • [2] Gastrointestinal function in intensive care patients: terminology, definitions and management. Recommendations of the ESICM Working Group on Abdominal Problems
    Blaser, Annika Reintam
    Malbrain, Manu L. N. G.
    Starkopf, Joel
    Fruhwald, Sonja
    Jakob, Stephan M.
    De Waele, Jan
    Braun, Jan-Peter
    Poeze, Martijn
    Spies, Claudia
    [J]. INTENSIVE CARE MEDICINE, 2012, 38 (03) : 384 - 394
  • [3] Propranolol and Oxandrolone Therapy Accelerated Muscle Recovery in Burned Children
    Chao, Tony
    Porter, Craig
    Herndon, David N.
    Siopi, Aikaterina
    Ideker, Henry
    Mlcak, Ronald P.
    Sidossis, Labros S.
    Suman, Oscar E.
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2018, 50 (03) : 427 - 435
  • [4] Gut dysfunction in the ICU: diagnosis and management
    Chapple, Lee-anne S.
    Plummer, Mark P.
    Chapman, Marianne J.
    [J]. CURRENT OPINION IN CRITICAL CARE, 2021, 27 (02) : 141 - 146
  • [5] Biomarker Evidence of the Persistent Inflammation, Immunosuppression and Catabolism Syndrome (PICS) in Chronic Critical Illness (CCI) After Surgical Sepsis
    Darden, Dijoia B.
    Brakenridge, Scott C.
    Efron, Philip A.
    Ghita, Gabriela L.
    Fenner, Brittany P.
    Kelly, Lauren S.
    Brumback, Babette
    Mohr, Alicia M.
    Moldawer, Lyle L.
    Moore, Frederick A.
    [J]. ANNALS OF SURGERY, 2021, 274 (04) : 664 - 673
  • [6] Ding RY, 2016, RETROSPECTIVE CLIN S, V55, P941
  • [7] Persistent inflammation and immunosuppression: A common syndrome and new horizon for surgical intensive care
    Gentile, Lori F.
    Cuenca, Alex G.
    Efron, Philip A.
    Ang, Darwin
    Bihorac, Azra
    McKinley, Bruce A.
    Moldawer, Lyle L.
    Moore, Frederick A.
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2012, 72 (06) : 1491 - 1501
  • [8] Chronic Critical illness and the Persistent Inflammation, Immunosuppression, and Catabolism Syndrome
    Hawkins, Russell B.
    Raymond, Steven L.
    Stortz, Julie A.
    Horiguchi, Hiroyuki
    Brakenridge, Scott C.
    Gardner, Anna
    Efron, Philip A.
    Bihorac, Azra
    Segal, Mark
    Moore, Frederick A.
    Moldawer, Lyle L.
    [J]. FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [9] Reversal of Growth Arrest With the Combined Administration of Oxandrolone and Propranolol in Severely Burned Children
    Herndon, David N.
    Voigt, Charles D.
    Capek, Karel D.
    Wurzer, Paul
    Guillory, Ashley
    Kline, Andrea
    Andersen, Clark R.
    Klein, Gordon L.
    Tompkins, Ronald G.
    Suman, Oscar E.
    Finnerty, Celeste C.
    Meyer, Walter J.
    Sousse, Linda E.
    [J]. ANNALS OF SURGERY, 2016, 264 (03) : 421 - 428
  • [10] Long-Term Propranolol Use in Severely Burned Pediatric Patients A Randomized Controlled Study
    Herndon, David N.
    Rodriguez, Noe A.
    Diaz, Eva C.
    Hegde, Sachin
    Jennings, Kristofer
    Mlcak, Ronald P.
    Suri, Jaipreet S.
    Lee, Jong O.
    Williams, Felicia N.
    Meyer, Walter
    Suman, Oscar E.
    Barrow, Robert E.
    Jeschke, Marc G.
    Finnerty, Celeste C.
    [J]. ANNALS OF SURGERY, 2012, 256 (03) : 402 - 411